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Abstract— recent research has shown that each apnea episode 
results in a significant rise in the beat-to-beat blood pressure and 
by a drop to the pre-episode levels when patient resumes normal 
breathing. While the physiological implications of these 
repetitive and significant oscillations are still unknown, it is of 
interest to quantify them. Since current array of instruments 
deployed for polysomnography studies does not include beat-to-
beat measurement of blood pressure, but includes oximetry, it is 
both of clinical interest to estimate the magnitude of BP 
oscillations from the photoplethysmography (PPG) signal that is 
readily available from sleep lab oximeters. We have investigated 
a new method for continuous estimation of systolic (SBP), 
diastolic (DBP), and mean (MBP) blood pressure waveforms 
from PPG. Peaks and troughs of PPG waveform are used as 
input to a 5th order autoregressive moving average model to 
construct estimates of SBP, DBP, and MBP waveforms. Since 
breath hold maneuvers are shown to simulate apnea episodes 
faithfully, we evaluated the performance of the proposed method 
in 7 subjects (4 F; 32±4 yrs., BMI 24.57±3.87 kg/m2) in supine 
position doing 5 breath maneuvers with 90s of normal breathing 
between them. The modeling error ranges were (all units are in 
mmHg) -0.88±4.87 to -2.19±5.73 (SBP); 0.29±2.39 to -0.97±3.83 
(DBP); and -0.42±2.64 to -1.17±3.82 (MBP). The cross validation 
error ranges were 0.28±6.45 to -1.74±6.55 (SBP); 0.09±3.37 to -
0.97±3.67 (DBP); and 0.33±4.34 to -0.87±4.42 (MBP). The level 
of estimation error in, as measured by the root mean squared of 
the model residuals, was less than 7 mmHg.  
I. INTRODUCTION 
Recently, investigators have shown the presence of 
significant oscillations in nocturnal blood pressure (BP) in a 
sample of obstructive sleep apnea (OSA) patients [1]. The 
significant level of these oscillations and their high frequency 
(occurring at every apnea episode) have heightened the 
interest of researchers to explore the extend of these 
oscillations in the larger samples of OSA patients, as such 
investigation may provide clues to root cause of the 
cardiovascular and cerebrovascular comorbidities of OSA.  
The knowledge of the extend of these oscillations is 
particularly important because numerous studies have shown 
sufficiency of the systolic blood pressure (SBP) and diastolic 
blood pressure (DBP) and computed Mean arterial blood 
pressure (MBP) as a predictor of mortality [2-5]. 
With current state of the art technology, quantification of 
the nocturnal oscillations in BP requires the use of rather 
costly devices that can provide beat-to-beat measure of BP 
(e.g., Finapres) in sleep studies. Considering that larger 
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population studies for this purpose, by necessity, involves 
multiple sleep labs. Given that measurement of nocturnal 
beat-to-beat BP is not part of the polysomnography studies in 
the sleep labs, it is of interest to develop methods of 
estimating the extent of apnea-driven BP oscillation from the 
equipment that are currently part of the standard 
polysomnography instrumentation.    
Recent studies have highlighted the benefits of using 
photoplethysmography (PPG) signal that is available from 
most, if not all, sleep laboratory oximeter to estimate the BP 
oscillations indirectly [6]. Indeed, some investigators have 
explored using pulse transit time (PTT) extracted from PPG 
to estimate BP in awake subjects [7-9]. These studies have 
shown a correlation coefficient of around 0.8 in experimental 
studies. However, the estimation of nocturnal BP oscillation 
has not been studied before.  
The objective of this study is to estimate the key features 
of blood pressure from PPG. Specifically, we estimate 
systolic BP (SBP), diastolic BP (DBP) and mean arterial BP 
(MBP) from PPG peaks and troughs.  The motivation is to 
accurately estimate and track the changes of BP during 
simulated sleep apnea by using photoplethysmograph probe 
which is easier to apply and less costly. 
II. METHOD 
We used peaks and troughs of the PPG waveform to model 
SBP and DBP correspondingly using Autoregressive 
Moving-average (ARMA) models. Using the estimated 
values of systolic and diastolic BP, we then estimated the 
MBP. ARMA model is a system identification method which 
can provide a mathematical model for the dynamics of the 
system as well as any pure time delay [10]. It has been shown 
to be efficient for the biological systems with multiple inputs 
and delays [11]. 
 For the purposes of this study, we apply a single input (i.e., 
PPG feature) and single output (i.e., BP feature). A single-
input-single-output, time-invariant, and causal ARMA model 
can be represented as a dynamic difference equation involving 
present and past values of the input and output as described in 
equation (2): 
𝑦𝑦(𝑚𝑚) + 𝑎𝑎1𝑦𝑦(𝑚𝑚 − 1) +⋯+ 𝑎𝑎𝑛𝑛𝑎𝑎𝑦𝑦(𝑚𝑚 − 𝑛𝑛𝑎𝑎) =      
𝑏𝑏1𝑢𝑢(𝑚𝑚 − 𝑛𝑛𝑘𝑘) +⋯+ 𝑏𝑏𝑛𝑛𝑏𝑏𝑢𝑢(𝑚𝑚 − 𝑛𝑛𝑏𝑏 − 𝑛𝑛𝑘𝑘 + 1) + 𝑒𝑒(𝑚𝑚)  (1) 
where m is the sample number, y is the output, u is the input 
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and e stands for error, 𝑎𝑎𝑖𝑖 for 𝑖𝑖 = 1,2 … ,𝑛𝑛𝑎𝑎 and 𝑏𝑏𝑗𝑗 for 𝑗𝑗 =1,2, … ,𝑛𝑛𝑏𝑏 are the model parameters that need to be computed, 
and na and nb signify the orders of ARMA model while nk is 
the number of pure-time delay samples. A major decision in 
developing an effective ARMA model is the selection of the 
order of the model and any pure-time delay that may be 
involved. In this study, we use principle of parsimony and 
model adequacy to find the least mean square error in a certain 
range of orders. A compromise was reached for the orders and 
the delays to be 5. Then ARMA model parameters are 
estimated in MATLAB using least square method to 
minimize the model error for specific orders. All the model 
subsets (with all possible combinations of orders) are 
generated and compared by their MSE. The lowest MSE is 
selected to be best model generated in the specified na and nb 
and nk. There are other methods including Akaike's 
information criterion (AIC) [12-13] to find the best model but 
it does not necessarily give the lowest MSE. In our study, we 
limited the model orders to be less than 5 and therefore there 
is no need for finding simplest model. These orders are 
selected based on trial and error as we compared higher orders 
models and did not see any significant improvement in 
results. 
A. Focal points on BP signal  
For this study, we opted to use SBP, DBP and MBP since 
these are proven to be in wide use in clinical practice as robust 
indicators of blood pressure health. The measured MBP was 
obtained from measured SBP and measured DBP using Eq. 
(2):   
𝑀𝑀𝑀𝑀𝑀𝑀 = 2𝐷𝐷𝐷𝐷𝐷𝐷+𝑆𝑆𝐷𝐷𝐷𝐷
3
      (2) 
In estimating the model parameters for estimating SBP and 
DBP (Eq. (1)), we use measured SBP and DBP as outputs and 
peaks and troughs of PPG signal as inputs, respectively. From 
estimated SBP and DBP – denoted as SB�P and 𝐷𝐷𝑀𝑀𝑀𝑀�  –, we 
compute the estimated MBP (i.e., 𝑀𝑀𝑀𝑀𝑀𝑀�  using Eq. (2). Since 
the application of the ARMA model (Eq. (2)) requires 
equidistance sampling of both the input and output data, we 
use cubic spline method to interpolate DBP, SBP and MBP 
values at the same sampling rate of the BP and PPG signal, 
i.e., 100 Hz. 
B. Experimental setup 
The protocol and written subject consent form for testing 
subjects were approved by our Human Subject Institutional 
Review Board. Seven subjects (4 F, 32±4 yrs., BMI 
24.57±3.87 kg/m2) with no known ailment volunteered for 
this study and signed the consent form. The subjects were 
asked to avoid any caffeine intake for 6 hours before the 
experiments. The subjects were tested in supine position, 
performing a sequence of five breath holding maneuvers. The 
sequence of the maneuvers is shown in Figure 1. At the start, 
each subject was asked to breathe normally for 60 s to obtain 
baseline data. Afterward each subject performed a series of 
five breath hold maneuvers to induce dynamic changes in BP 
change. During each breath hold (BH), subjects were 
instructed to hold their breath for as long as they can. Hence, 
the duration of each breath hold varied, depending on the 
ability of the subject to prolong the breath hold. Inter breath 
hold intervals, i.e. normal breathings (NB), were fixed at 90 
seconds to provide adequate recovery time between 
consecutive breath holds. Data was collected for the entire 
duration, from the initial baseline through the final ‘ending 
NB’ period (Fig. 1).  
 
Figure 1- Timing diagram of protocols (NB: Normal breathing, BH: Breath 
hold) 
We used a Finapres blood pressure monitor (Finapres 
Medical Systems, Enschede, Netherlands) for beat-to-beat 
measurement of BP [14]. Photoplethysmography signal was 
acquired using Nellcor OxiMax N-600x monitor (Medtronic, 
Minneapolis, USA). Although the signals were acquired at 
1000 sample per second, both BP and PPG signals were down 
sampled to 100 samples per second. This was done to make 
computation of the models more efficient, while still 
preserving the important dynamics of the signal. A typical 
blood pressure signal and its systolic and diastolic values are 
shown in Fig. 2. The black line shows the breath holds 
intervals whenever it jumps up. At its low values, the subject 
is in normal breathing condition. Obviously, the blood 
pressure follows a rising trend during BHs and it can be seen 
in both systolic values interpolated in red and diastolic values 
interpolated in green. 
C. Model Implementation  
Applying ARMA model (Eq. (1)), we obtained the model 
parameters for estimating SBP (i.e.,SB�P) and DBP (i.e., DB�P) 
from PPG signal.  ARMA models for each of the five BH 
intervals were calculated separately for both systolic and 
diastolic BP in all 7 subjects. In other words, we obtained 5 
SBP model and 5 DBP model for each subject. Then, for both 
measured MBP and estimated MBP (i.e. MA�P), we applied 
Eq. (2).  
 
Figure 2- BP signal and systolic and diastolic interpolated values during 
breath-hold 
  
 
Figure 3- Estimated MBP signal versus Measured MBP from the same 
interval (Modeling) 
 
Figure 4- Estimated MBP signal versus measured MBP in another 
interval (Validation) 
D. Model and Cross Validation 
To ascertain the accuracy and predictive ability of the models, 
we conducted two types of evaluations. First, we computed 
the residuals for the model by computing the difference 
between the experimentally measured (e.g., SBP) and the 
model estimate of the output (e.g. SB�P); referred to as Model 
Errors. Second, we computed the cross validation errors by 
applying a model obtained using one interval to predict the 
BP in other intervals. We computed the cross validation errors 
for all unique permutations of models.  
III. RESULTS 
Diastolic values are shown in Fig.2.  The straight black 
lines denote the breath holds interval (high level) and normal 
breathing condition (low level). The rise in blood pressure 
during BH and its drop afterwards can be easily seen.  
Fig. 3 shows a sample of computed MA�P superimposed on 
the respective measured values of MBP from the same 
interval (in this case, BH2).  Fig. 4 shows the estimated MA�P 
superimposed on measured MBP validated in another interval 
(in this case, BH2 validated with BH3). 
The mean ± standard deviation of the model and cross 
validation errors for all SBP, DBP, and MBP are shown in 
Table 1 and Table 2, respectively. 
 
Table 1- Mean±Std.Dev. of model errors for each BH interval (in 
mmHg) 
 1st BH 2nd BH 3rd BH 4th BH 5th BH 
Systolic 1.00±3.77 -0.29±3.81 -2.19±5.73 -0.88±4.87 -0.62±4.88 
Diastolic 0.29±+2.39 -0.49±2.63 -0.66±3.98 -0.31±3.16 -0.97±3.63 
MBP 0.53±2.32 -0.42±2.64 -1.17±3.82 -0.50±3.14 -0.85±3.53 
 
Table 2- Mean±Std.Dev. of cross validation errors of each BH 
interval obtained using models of all other BH intervals (in mmHg) 
 1st BH 2nd BH 3rd BH 4th BH 5th BH 
Systolic 0.28±6.45 0.20±5.49 -1.74±6.55 -0.93±5.10 -0.64±4.91 
Diastolic 0.35±4.08 0.09±3.37 -0.44±4.37 -0.46±3.55 -0.97±3.67 
MBP 0.33±4.34 0.13±3.64 -0.87±4.42 -0.62±3.49 -0.86±3.56 
 
To estimate the accuracy of the values of SB�P, DB�P, and  MA�P obtained from each model, the root mean square error 
(rMSE) for the Model Errors for all BH intervals were 
computed. The results of averaging the rMSE values derived 
from the model errors for all subjects are tabulated in Table 3. 
To assess how a model developed from the data of one 
interval (e.g. BH1) predicts the corresponding BP measures 
(i.e. SBP, DBP or MBP) of another congruent interval, we 
computed the rMSE of the cross validation errors for BH and 
tabulated them in Table 4.  
 
Table 3- rMSEs of model errors of BH intervals (in mmHg) 
 1st BH 2nd BH 3rd BH 4th BH 5th BH 
Systolic 3.90 3.83 5.11 4.95 4.92 
Diastolic 2.41 2.68 4.03 3.18 3.76 
MBP 2.38 2.67 4.00 3.18 3.63 
 
Table 4- rMSEs of validation of each BH interval by all other BH 
intervals (in mmHg) 
 1st BH 2nd BH 3rd BH 4th BH 5th BH 
Systolic 6.46 5.49 6.78 5.18 4.95 
Diastolic 4.10 3.37 4.39 3.58 3.80 
MBP 4.35 3.65 4.50 3.54 3.66 
 
IV. DISCUSSION 
Fig. 3 and Fig. 4 show that  MA�P well track the overall 
rising trends of the MBP signals during the BH intervals. The 
means of the model errors and cross validation errors in 
Table1 and Table 2 provide an assessment of the level of 
accuracy of estimation of the SBP, DBP, and MBP. As can be 
seen, the largest estimation errors for BH interval is less than   
2.19 mmHg. Indeed, a majority of the cases have error means 
that are within ±1 mmHg. With taking the level of dispersion 
of the errors in Table 1 and Table 2 into consideration, it can 
be seen that the standard deviations for the modeling and 
  
validation errors for BH intervals are all below 5 mmHg. This 
relatively small window of variation is also corroborated by 
rMSE values that are shown in Table 3 and Table 4. 
 As can be seen from the results shown in these tables, the 
upper bound for the dispersion of the cross validation errors 
is larger than dispersion for model errors (i.e. 6.55 vs 5.73 
mmHg, respectively). This is somewhat expected as Cross 
Validation Errors reflect the ability of the models in 
predicting BP under the condition different from the condition 
that model was derived for. In particular, the experimental 
protocol was designed to examine the effect of successive 
breath holds on the estimation of BP. In future, we will be 
reporting on the analysis of NB portion of the experimental 
protocol. 
 Comparing the rMSE values in Table 3 with those in Table 
4 shows that rMSE values have a max mean of approximately 
7 mmHg. Hence, if rMSE is used to gauge the level of the 
error, for both Model Errors and Cross Validation Errors, an 
overall error of less than 7 mmHg can be expected. When 
compared with some of the previously reported techniques, 
one finds that our results are comparable to techniques which 
used PTT in estimating BP from PPG signals [15]. These 
findings show that ARMA model approach is capable of 
tracking slow frequency trend and also high frequency 
hemodynamic changes of the body and exhibit adequate 
accuracy for possible clinical applications.  
It is noted, however, that it is unlikely that a single model 
would be able to estimate BP for members of all population 
sectors from the PPG variations.  The likely need for person-
specific models stems from the fact that there is a wide 
variation in the physiological systems involved in the control 
of blood pressure which includes responsiveness of the 
sympathetic nervous system, mechanical, fluid mechanics, 
dynamical properties of the cardiovascular system, and 
metabolic rate. 
V. CONCLUSION 
The findings of this pilot study demonstrate that estimating 
systolic and diastolic BP from PPG measurements using 
ARMA models can be a viable method for continuous and 
non-invasive measurement of key BP focal points in OSA 
subjects with accuracy levels comparable to previously 
reported values.  
 
VI. REFERENCES 
[1]  H. Sekizuka, K. Kida, Y. J. Akashi, K. Yoneyama, N. Osada, 
K. Omiya, F. Miyak, "Relationship between sleep apnea 
syndrome and sleep blood pressure in patients without 
hypertension," Journal of Cardiology, vol. 55, no. 1, pp. 92-
98, 2010.  
[2]  M. J. Domanski, G. F. Mitchell, J. E. Norman, D. V. Exner, 
B. Pitt, M. A. Pfeffer, "Independent prognostic information 
provided by sphygmomanometrically determined pulse 
pressure and mean arterial pressure in patients with left 
ventricular dysfunction," Journal of American college of 
Cardiology, vol. 33, no. 4, pp. 951-958, 1999.  
[3]  L. Palaniappan, L. A. Simons, J. Simons, Y. Friedlander, J. 
McCallum, "Comparison of Usefulness of Systolic, Diastolic, 
and Mean Blood Pressure and Pulse Pressure as Predictors of 
Cardiovascular Death in Patients ≥60 Years of Age," 
American Journal of Cardiology, vol. 90, no. 12, pp. 1398-
1401, 2002.  
[4]  B. C. Taylor, T. J. Wilt, H. G. Welch, "Impact of Diastolic 
and Systolic Blood Pressure on Mortality: Implications for the 
Definition of “Normal”," Journal of General Internal 
Medicine, vol. 26, no. 7, pp. 685-690, 2011.  
[5]  V. Kovacic, L. Roguljic, V. Kovacic, B. Bacic, T. Bosnjak, 
"Mean arterial pressure and pulse pressure are associated with 
different clinical parameters in chronic haemodialysis 
patients," Journal of Human Hypertension, vol. 17, pp. 353-
360, 2003.  
[6]  E. C. Chua, S. J. Redmond, G. McDarby and C. Heneghan, 
"Towards using photoplethysmogram amplitude to measure 
blood pressure during sleep," Annals of Biomedical 
Engineering, vol. 38, no. 3, pp. 945-954, 2010.  
[7]  H. Gesche, D. Grosskurth, G. Kuchler, A. Patzak, 
"Continuous blood pressure measurement by using the pulse 
transit time: comparison to a cuff-based method," European 
Journal of Applied Physiology, vol. 112, no. 1, pp. 309-315, 
2012.  
[8]  H. Schmalgemeier, T. Bitter, S. Bartsch, K. Bullert, T. 
Fischbach, S. Eckert, D. Horstkotte, O. Oldenburg, "Pulse 
transit time: validation of blood pressure measurement under 
positive airway pressure ventilation," Sleep and Breathing, 
vol. 16, no. 4, pp. 1105-1112, 2012.  
[9]  R. Smith, J. Argod, J. Pepin, P. Levy, "Pulse transit time: an 
appraisal of potential clinical applications," Thorax, vol. 54, 
no. 5, pp. 452-457, 1999.  
[10]  L. Ljung, System Identification: Theory for the user, Second 
ed., Upper Saddle River, NJ: Printice Hall, 1999.  
[11]  M. H. Perrott and R J. Cohen, An Efficient Approach to 
ARMA Modeling of Biological Systems with Multiple Inputs 
and Delays," IEEE Transaction on Biomedical Engineering, 
vol. 43, No. 1, 1996.  
[12]  H. Akaike, "Fitting Autoregressive Models For Prediction," 
Annals of the Institute of Statistical Mathematics, vol. 21, no. 
1, pp. 243-247, 1969.  
[13]  H. Akaike, "On The Use of A Linear Model For The 
Identification of Feedback Systems," Annals of the Institute 
of Statistical Mathematics, vol. 20, no. 1, pp. 425-439, 1968.  
[14]  B. P. Imholz, W. Wieling, G. A. van Montfrans, K. H. 
Wesseling , "Fifteen years experience with finger arterial 
pressure monitoring: assessment of the technology," 
Cardiovasc Res., vol. 28, no. 3, pp. 605-616, 1998.  
[15]  A. Patzak, Y. Mendoza, H. Gesche, M. Konermann, 
"Continuous blood pressure measurement using the pulse 
transit time: Comparison to intra-arterial measurement," 
Blood press, vol. 24, no. 4, pp. 217-221, 2015.  
 
 
